Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

by Sebastian Chrétien, Ioannis Zerdes, Jonas Bergh, Alexios Matikas, Theodoros Foukakis
Published 2019-05-01

Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen recep...

by Ioannis Zerdes, Emmanouil G. Sifakis, Alexios Matikas, Sebastian Chrétien, Nicholas P. Tobin, Johan Hartman, George Z. Rassidakis, Jonas Bergh, Theodoros Foukakis
Published 2020-05-01